0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Open-Angle Glaucoma Therapeutics Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-30H13902
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Open Angle Glaucoma Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Open-Angle Glaucoma Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-30H13902
Report
December 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Open-Angle Glaucoma Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Open-Angle Glaucoma Therapeutics Market

Open-Angle Glaucoma Therapeutics Market

Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss.
Market Analysis and Insights: Global Open-Angle Glaucoma Therapeutics Market
The global Open-Angle Glaucoma Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Open-Angle Glaucoma Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Open-Angle Glaucoma Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Open-Angle Glaucoma Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Open-Angle Glaucoma Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Open-Angle Glaucoma Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Open-Angle Glaucoma Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Open-Angle Glaucoma Therapeutics Market Report

Report Metric Details
Report Name Open-Angle Glaucoma Therapeutics Market
CAGR 5%
Segment by Type
  • Prostaglandin Analogs (PGAs)
  • Combination of PGAs
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Research Institute
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aerie Pharmaceuticals Inc., Allergan Plc, Bausch Health Companies, Inc., Novartis AG, Pfizer Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Open-Angle Glaucoma Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Open-Angle Glaucoma Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Open-Angle Glaucoma Therapeutics revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Open-Angle Glaucoma Therapeutics Market report?

Ans: The main players in the Open-Angle Glaucoma Therapeutics Market are Aerie Pharmaceuticals Inc., Allergan Plc, Bausch Health Companies, Inc., Novartis AG, Pfizer Inc.

What are the Application segmentation covered in the Open-Angle Glaucoma Therapeutics Market report?

Ans: The Applications covered in the Open-Angle Glaucoma Therapeutics Market report are Hospital, Clinic, Research Institute, Other

What are the Type segmentation covered in the Open-Angle Glaucoma Therapeutics Market report?

Ans: The Types covered in the Open-Angle Glaucoma Therapeutics Market report are Prostaglandin Analogs (PGAs), Combination of PGAs, Other

Recommended Reports

Ophthalmic Therapeutics

Ocular Drug Delivery

Eye Disease Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Prostaglandin Analogs (PGAs)
1.2.3 Combination of PGAs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Open-Angle Glaucoma Therapeutics Market Perspective (2019-2030)
2.2 Global Open-Angle Glaucoma Therapeutics Growth Trends by Region
2.2.1 Open-Angle Glaucoma Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Open-Angle Glaucoma Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Open-Angle Glaucoma Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Open-Angle Glaucoma Therapeutics Market Dynamics
2.3.1 Open-Angle Glaucoma Therapeutics Industry Trends
2.3.2 Open-Angle Glaucoma Therapeutics Market Drivers
2.3.3 Open-Angle Glaucoma Therapeutics Market Challenges
2.3.4 Open-Angle Glaucoma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Open-Angle Glaucoma Therapeutics by Players
3.1.1 Global Open-Angle Glaucoma Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Open-Angle Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Open-Angle Glaucoma Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio
3.4.1 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Open-Angle Glaucoma Therapeutics Revenue in 2023
3.5 Global Key Players of Open-Angle Glaucoma Therapeutics Head office and Area Served
3.6 Global Key Players of Open-Angle Glaucoma Therapeutics, Product and Application
3.7 Global Key Players of Open-Angle Glaucoma Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Open-Angle Glaucoma Therapeutics Breakdown Data by Type
4.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2025-2030)
5 Open-Angle Glaucoma Therapeutics Breakdown Data by Application
5.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
6.2 North America Open-Angle Glaucoma Therapeutics Market Size by Type
6.2.1 North America Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
6.3 North America Open-Angle Glaucoma Therapeutics Market Size by Application
6.3.1 North America Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
6.4 North America Open-Angle Glaucoma Therapeutics Market Size by Country
6.4.1 North America Open-Angle Glaucoma Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
7.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Type
7.2.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
7.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Application
7.3.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
7.4 Europe Open-Angle Glaucoma Therapeutics Market Size by Country
7.4.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
8.2 China Open-Angle Glaucoma Therapeutics Market Size by Type
8.2.1 China Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024)
8.2.2 China Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030)
8.2.3 China Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
8.3 China Open-Angle Glaucoma Therapeutics Market Size by Application
8.3.1 China Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024)
8.3.2 China Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030)
8.3.3 China Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
9.2 Asia Open-Angle Glaucoma Therapeutics Market Size by Type
9.2.1 Asia Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
9.3 Asia Open-Angle Glaucoma Therapeutics Market Size by Application
9.3.1 Asia Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
9.4 Asia Open-Angle Glaucoma Therapeutics Market Size by Region
9.4.1 Asia Open-Angle Glaucoma Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Open-Angle Glaucoma Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Open-Angle Glaucoma Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Aerie Pharmaceuticals Inc.
11.1.1 Aerie Pharmaceuticals Inc. Company Details
11.1.2 Aerie Pharmaceuticals Inc. Business Overview
11.1.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Introduction
11.1.4 Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.1.5 Aerie Pharmaceuticals Inc. Recent Developments
11.2 Allergan Plc
11.2.1 Allergan Plc Company Details
11.2.2 Allergan Plc Business Overview
11.2.3 Allergan Plc Open-Angle Glaucoma Therapeutics Introduction
11.2.4 Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.2.5 Allergan Plc Recent Developments
11.3 Bausch Health Companies, Inc.
11.3.1 Bausch Health Companies, Inc. Company Details
11.3.2 Bausch Health Companies, Inc. Business Overview
11.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Introduction
11.3.4 Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.3.5 Bausch Health Companies, Inc. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Open-Angle Glaucoma Therapeutics Introduction
11.4.4 Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.4.5 Novartis AG Recent Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Introduction
11.5.4 Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.5.5 Pfizer Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Prostaglandin Analogs (PGAs)
    Table 3. Key Players of Combination of PGAs
    Table 4. Key Players of Other
    Table 5. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Open-Angle Glaucoma Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Open-Angle Glaucoma Therapeutics Market Share by Region (2019-2024)
    Table 9. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Open-Angle Glaucoma Therapeutics Market Share by Region (2025-2030)
    Table 11. Open-Angle Glaucoma Therapeutics Market Trends
    Table 12. Open-Angle Glaucoma Therapeutics Market Drivers
    Table 13. Open-Angle Glaucoma Therapeutics Market Challenges
    Table 14. Open-Angle Glaucoma Therapeutics Market Restraints
    Table 15. Global Open-Angle Glaucoma Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Open-Angle Glaucoma Therapeutics Revenue Share by Players (2019-2024)
    Table 17. Global Top Open-Angle Glaucoma Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2023)
    Table 18. Global Open-Angle Glaucoma Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Open-Angle Glaucoma Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Open-Angle Glaucoma Therapeutics, Headquarters and Area Served
    Table 21. Global Key Players of Open-Angle Glaucoma Therapeutics, Product and Application
    Table 22. Global Key Players of Open-Angle Glaucoma Therapeutics, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2019-2024)
    Table 26. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2025-2030)
    Table 28. Global Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Open-Angle Glaucoma Therapeutics Revenue Share by Application (2019-2024)
    Table 30. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Open-Angle Glaucoma Therapeutics Revenue Share by Application (2025-2030)
    Table 32. North America Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Open-Angle Glaucoma Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Open-Angle Glaucoma Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Open-Angle Glaucoma Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Open-Angle Glaucoma Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Open-Angle Glaucoma Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Aerie Pharmaceuticals Inc. Company Details
    Table 65. Aerie Pharmaceuticals Inc. Business Overview
    Table 66. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product
    Table 67. Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)
    Table 68. Aerie Pharmaceuticals Inc. Recent Developments
    Table 69. Allergan Plc Company Details
    Table 70. Allergan Plc Business Overview
    Table 71. Allergan Plc Open-Angle Glaucoma Therapeutics Product
    Table 72. Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)
    Table 73. Allergan Plc Recent Developments
    Table 74. Bausch Health Companies, Inc. Company Details
    Table 75. Bausch Health Companies, Inc. Business Overview
    Table 76. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product
    Table 77. Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)
    Table 78. Bausch Health Companies, Inc. Recent Developments
    Table 79. Novartis AG Company Details
    Table 80. Novartis AG Business Overview
    Table 81. Novartis AG Open-Angle Glaucoma Therapeutics Product
    Table 82. Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)
    Table 83. Novartis AG Recent Developments
    Table 84. Pfizer Inc. Company Details
    Table 85. Pfizer Inc. Business Overview
    Table 86. Pfizer Inc. Open-Angle Glaucoma Therapeutics Product
    Table 87. Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024) & (US$ Million)
    Table 88. Pfizer Inc. Recent Developments
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Open-Angle Glaucoma Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Prostaglandin Analogs (PGAs) Features
    Figure 4. Combination of PGAs Features
    Figure 5. Other Features
    Figure 6. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Open-Angle Glaucoma Therapeutics Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Research Institute Case Studies
    Figure 11. Other Case Studies
    Figure 12. Open-Angle Glaucoma Therapeutics Report Years Considered
    Figure 13. Global Open-Angle Glaucoma Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Open-Angle Glaucoma Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Open-Angle Glaucoma Therapeutics Market Share by Region: 2023 VS 2030
    Figure 16. Global Open-Angle Glaucoma Therapeutics Market Share by Players in 2023
    Figure 17. Global Top Open-Angle Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Open-Angle Glaucoma Therapeutics Revenue in 2023
    Figure 19. North America Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
    Figure 21. North America Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
    Figure 22. North America Open-Angle Glaucoma Therapeutics Market Share by Country (2019-2030)
    Figure 23. United States Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Open-Angle Glaucoma Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
    Figure 27. Europe Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
    Figure 28. Europe Open-Angle Glaucoma Therapeutics Market Share by Country (2019-2030)
    Figure 29. Germany Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Open-Angle Glaucoma Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
    Figure 37. China Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
    Figure 38. Asia Open-Angle Glaucoma Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
    Figure 40. Asia Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
    Figure 41. Asia Open-Angle Glaucoma Therapeutics Market Share by Region (2019-2030)
    Figure 42. Japan Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Open-Angle Glaucoma Therapeutics Market Share by Country (2019-2030)
    Figure 52. Brazil Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Aerie Pharmaceuticals Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)
    Figure 59. Allergan Plc Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)
    Figure 60. Bausch Health Companies, Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)
    Figure 61. Novartis AG Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)
    Figure 62. Pfizer Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2019-2024)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD